China NT Pharma Group Company Limited (HKG:1011)
Hong Kong · Delayed Price · Currency is HKD 0.7500
0.00 (0.00%)
At close: Feb 13, 2026
HKG:1011 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -70.92 | -53.36 | -143.59 | -66.41 | -149.54 | -357.6 |
Depreciation & Amortization | 0.47 | 0.66 | 5.55 | 20.65 | 41.82 | 23.9 |
Other Amortization | - | - | 0.33 | 5.53 | 0.43 | 0.5 |
Loss (Gain) From Sale of Assets | 7.01 | 7.01 | -12.29 | - | -41.04 | -0.3 |
Asset Writedown & Restructuring Costs | 0.12 | 0.12 | 0.01 | 0.08 | - | -10.98 |
Loss (Gain) From Sale of Investments | 5.92 | 5.92 | - | 0.63 | 6.04 | - |
Loss (Gain) on Equity Investments | -10.24 | -10.24 | -37.04 | -9 | -34.49 | -0.01 |
Stock-Based Compensation | - | - | - | 0.6 | 0.08 | 0.1 |
Provision & Write-off of Bad Debts | - | - | 1.66 | 0.25 | 9.74 | 6.32 |
Other Operating Activities | 41.94 | 37.68 | 160.82 | 100.33 | 124.23 | 312.47 |
Change in Accounts Receivable | -1 | -1 | 67.33 | -32.11 | 7.94 | 26.54 |
Change in Inventory | -0.17 | -0.17 | -2.53 | 19.88 | -5.19 | 6.78 |
Change in Accounts Payable | 4.31 | 4.31 | 16.72 | -1.03 | -94.81 | 102.1 |
Change in Other Net Operating Assets | - | - | - | 1.06 | -0.56 | - |
Operating Cash Flow | -22.56 | -9.07 | 50.48 | 36.21 | -135.34 | 26.2 |
Operating Cash Flow Growth | - | - | 39.40% | - | - | -45.14% |
Capital Expenditures | -0.18 | -0.18 | -10.73 | -4.49 | -0.65 | -23.84 |
Sale of Property, Plant & Equipment | - | - | 0.16 | - | 32.56 | - |
Cash Acquisitions | - | - | - | - | -4.97 | -1.03 |
Divestitures | -0.02 | -0.02 | -0.2 | - | 438.71 | 558.37 |
Sale (Purchase) of Intangibles | - | - | -2.16 | - | - | - |
Investment in Securities | - | - | - | 9 | -232.59 | 44.79 |
Other Investing Activities | 0.15 | 0.01 | -9.21 | 0.02 | 24.76 | 17.32 |
Investing Cash Flow | -0.06 | -0.19 | -22.14 | 4.53 | 257.81 | 595.6 |
Long-Term Debt Issued | - | 30.67 | 18.08 | 53.38 | 83.22 | 1,181 |
Total Debt Issued | 30.67 | 30.67 | 18.08 | 53.38 | 83.22 | 1,181 |
Long-Term Debt Repaid | - | -8.03 | -37.2 | -82.38 | -164.69 | -1,739 |
Total Debt Repaid | -8.03 | -8.03 | -37.2 | -82.38 | -164.69 | -1,739 |
Net Debt Issued (Repaid) | 22.64 | 22.64 | -19.12 | -29 | -81.47 | -558.16 |
Issuance of Common Stock | - | - | 9.39 | 2.02 | - | - |
Other Financing Activities | 0.38 | -9.99 | -19.24 | -19.7 | -43.33 | -66.08 |
Financing Cash Flow | 23.02 | 12.65 | -28.97 | -46.68 | -124.8 | -624.25 |
Foreign Exchange Rate Adjustments | -1.56 | 4.71 | 0.24 | 3.49 | 3.37 | -17.92 |
Net Cash Flow | -1.16 | 8.1 | -0.4 | -2.45 | 1.05 | -20.36 |
Free Cash Flow | -22.74 | -9.24 | 39.74 | 31.72 | -135.98 | 2.36 |
Free Cash Flow Growth | - | - | 25.31% | - | - | -79.88% |
Free Cash Flow Margin | -121.87% | -24.35% | 539.55% | - | -59.98% | 1.06% |
Free Cash Flow Per Share | -0.06 | -0.04 | 0.17 | 0.17 | -0.72 | 0.01 |
Cash Interest Paid | 9.99 | 9.99 | 18.77 | 17.57 | 42.86 | 65.37 |
Cash Income Tax Paid | - | - | 0.86 | 1.04 | 0.8 | -0.05 |
Levered Free Cash Flow | -74.38 | 10.18 | 14.34 | 238.01 | 159.33 | -739.96 |
Unlevered Free Cash Flow | -49.29 | 29.89 | 32.36 | 262.61 | 214.78 | -686.77 |
Change in Working Capital | 3.15 | 3.15 | 81.52 | -12.19 | -92.62 | 135.42 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.